About us
Services & Solutions
Chemistry DMPK Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry Parallel Synthesis
Flow Chemistry Kilo and Pilot Scale Production RSM and Intermediates Manufacturing QA EHS
Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
CN EN
×
news
Company News Events Insights Webinars Virtual Tours
BioDuro-Sundia’s Partner, DigmBio Announced IND Clearance from Korea MFDS for its Selective PARP1 Inhibitor DM5167
Shanghai, March 26, 2024 – BioDuro-Sundia's partner, DigmBio, a South Korean biotechnology company, announced its selective PARP1 inhibitor for the treatment of triple-negative breast cancer has b
March 26, 2024
StoneWise Awards BioDuro-Sundia FTE team in Chemistry Department for Best Contributing Team of 2023
Beijing, February 6th, 2024 – The technical services of BioDuro-Sundia FTE team of Chemistry Department were once again recognized by its partners. StoneWise representatives Guanglong Sun, Director of
February 06, 2024
Inna Pharma Presents "2023 Outstanding Partner Award" to BioDuro-Sundia CMC Team
Shanghai, December 26, 2023 - The technical services of BioDuro-Sundia CMC department were once again recognized by its partners. Xu Wang, Director of Inna, Biguang Zhong, Executive Director, and Lili
December 26, 2023
Asieris Pharmaceuticals Presents "2023 Outstanding Contribution Award" to BioDuro-Sundia Formulation Team
Shanghai, December 15, 2023 - The pre-formulation team of BioDuro-Sundia Formulation Department has been awarded the "2023 Outstanding Contribution Award" for its outstanding performance in
December 15, 2023
BioDuro-Sundia Radioisotope Laboratory Technology Upgrades Accelerate Innovation
Shanghai, November 15, 2023 – Radioisotope assays a microanalytical method that uses radionuclides as tracers to label research objects. Compared with conventional biological sample detection tec
November 15, 2023
Total 84 12345678...1617
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all